| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.27B | 39.68B | 66.62B | 39.33B | 76.11B |
| Gross Profit | -2.13B | 906.94M | 3.18B | 3.50B | 13.03B |
| EBITDA | -2.98B | -256.26M | 789.39M | 247.59M | 8.36B |
| Net Income | -4.08B | -2.43B | -4.25B | -1.35B | 2.70B |
Balance Sheet | |||||
| Total Assets | 112.13B | 133.18B | 180.77B | 237.82B | 267.18B |
| Cash, Cash Equivalents and Short-Term Investments | 3.36B | 5.78B | 10.70B | 16.62B | 27.79B |
| Total Debt | 17.71B | 20.25B | 21.17B | 26.78B | 39.95B |
| Total Liabilities | 99.79B | 113.80B | 154.37B | 206.44B | 231.70B |
| Stockholders Equity | 420.33M | 4.54B | 6.89B | 11.11B | 11.96B |
Cash Flow | |||||
| Free Cash Flow | -2.59B | -2.70B | -2.21B | 10.94B | 17.78B |
| Operating Cash Flow | -2.58B | -2.69B | -2.19B | 10.95B | 17.81B |
| Investing Cash Flow | 1.39B | 3.52B | 2.85B | 1.24B | -6.19B |
| Financing Cash Flow | -1.16B | -4.52B | -8.03B | -17.88B | -17.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$821.23M | 0.11 | 260.87% | ― | 82.96% | ― | |
46 Neutral | HK$652.50M | -59.48 | -9.32% | ― | -35.76% | 81.82% | |
45 Neutral | HK$415.90M | -0.66 | -21.15% | ― | 26.59% | 57.31% | |
43 Neutral | HK$252.00M | -1.22 | ― | ― | ― | ― | |
41 Neutral | HK$195.84M | -0.06 | -34.31% | ― | -69.02% | -41.71% | |
40 Underperform | HK$185.18M | -0.02 | 55.65% | ― | -75.81% | 16.54% |